Alkem Labs Q2 Results: Net profit rises 11% to Rs 689 crore

economictimes.indiatimes.com:

Alkem Laboratories on Wednesday posted a 11% year-on-year (y-o-y) jump in net profit to Rs 689 crore in Q2FY25 led by growth in domestic formulation sales.

The company reported Rs 620.5 crore in the corresponding quarter of the previous year.

Revenue from operations declined 0.7% y-o-y to Rs 3414.7 crore in Q2FY25.

Earnings before interest, tax, depreciation, and amortization (EBITDA) increased by 0.8% y-o-y to Rs 753 crore, resulting in an EBITDA margin of 22% in Q2FY22 compared to 21.7% in Q2FY24.

R&D expenses for the quarter were Rs 146.5 crore or 4.3% of total revenue from operations.

• Stock Trading

  Ichimoku Trading Unlocked: Expert Analysis and Strategy

  By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert

• Stock Trading

  Advanced Strategies in Stock Market Mastery

  By — CA Raj K Agrawal, Chartered Accountant

• Stock Trading

  RSI Made Easy: RSI Trading Course

  By — Souradeep Dey, Equity and Commodity Trader, Trainer

• Stock Trading

  Stock Valuation Made Easy

  By — Rounak Gouti, Investment commentary writer, Experience in equity research

• Stock Trading

  Technical Analysis Demystified: A Complete Guide to Trading

  By — Kunal Patel, Options Trader, Instructor

• Stock Trading

  Heikin Ashi Trading Tactics: Master the Art of Trading

  By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert

• Stock Trading

  Market 104: Options Trading: Kickstart Your F&O Adventure

  By — Saketh R, Founder- QuickAlpha, Full Time Options Trader

• Stock Trading

  Complete Guide to Stock Market Trading: From Basics to Advanced

  By —